RLAY Q4 2023 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$1,000-100.4% YoY

Gross Profit

-$1,000100.0% margin

Operating Income

-$92M9219600.0% margin

Net Income

-$83M8349500.0% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$89M

Free Cash Flow

-$89M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$844M

Total Liabilities

$92M

Stockholders' Equity

$752M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$1,000	$253,000	-100.4%
Gross Profit	-$1,000	-$64M	+100.0%
Operating Income	-$92M	-$73M	-26.6%
Net Income	-$83M	-$68M	-23.7%